We demonstrated for the first time that Rfvt3 contributes to placental riboflavin transport, and disruption of Slc52a3 caused neonatal lethality with hyperlipidemia and hypoglycemia owing to riboflavin deficiency. This evidence concerns the gene SLC52A3 and Hypoglycemia.